Login / Signup

Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma.

Elisabet E ManasanchPreetesh JainWendy ChenOnyeka OriabureMaria BadilloLei FengZuzana BerkovaRobert Z OrlowskiMichael L Wang
Published in: American journal of hematology (2020)
Keyphrases
  • multiple myeloma
  • high dose
  • low dose
  • stem cell transplantation
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • diffuse large b cell lymphoma
  • hodgkin lymphoma